23359-100 NDC - CENTRATEX (IRON, SODIUM ASCORBATE, THIAMINE MONONITRATE, RIBOFLAVIN, PYRIDOXINE HYDROCHLORIDE, FOLIC ACID, CYANOCOBALAMIN, NIACINAMIDE, CALCIUM PANTOTHENATE, ZINC SULFATE, MAGNESIUM SULFATE, MANGANESE SULFATE, AND CUPRIC SULFATE ANHYDROUS)

Drug Information

Product NDC: 23359-100

Proprietary Name: Centratex

Non Proprietary Name: Iron, Sodium Ascorbate, Thiamine Mononitrate, Riboflavin, Pyridoxine Hydrochloride, Folic Acid, Cyanocobalamin, Niacinamide, Calcium Pantothenate, Zinc Sulfate, Magnesium Sulfate, Manganese Sulfate, and Cupric Sulfate Anhydrous

Active Ingredient(s):
  • 10 mg/1 CALCIUM PANTOTHENATE;
  • .8 mg/1 CUPRIC SULFATE ANHYDROUS;
  • 15 ug/1 CYANOCOBALAMIN;
  • 1 mg/1 FOLIC ACID;
  • 106 mg/1 IRON;
  • 6.9 mg/1 MAGNESIUM SULFATE, UNSPECIFIED;
  • 1.3 mg/1 MANGANESE SULFATE;
  • 30 mg/1 NIACINAMIDE;
  • 5 mg/1 PYRIDOXINE HYDROCHLORIDE;
  • 6 mg/1 RIBOFLAVIN;
  • 200 mg/1 SODIUM ASCORBATE;
  • 10 mg/1 THIAMINE MONONITRATE;
  • 18.2 mg/1 ZINC SULFATE


Administration Route(s): ORAL

Dosage Form(s): CAPSULE

Pharmacy Class(es):
  • Analogs/Derivatives [Chemical/Ingredient];
  • Ascorbic Acid [CS];
  • Blood Coagulation Factor [EPC];
  • Calcium [CS];
  • Calculi Dissolution Agent [EPC];
  • Cations;
  • Divalent [CS];
  • Copper Absorption Inhibitor [EPC];
  • Decreased Copper Ion Absorption [PE];
  • Increased Coagulation Factor Activity [PE];
  • Increased Large Intestinal Motility [PE];
  • Inhibition Large Intestine Fluid/Electrolyte Absorption [PE];
  • Inhibition Small Intestine Fluid/Electrolyte Absorption [PE];
  • Magnesium Ion Exchange Activity [MoA];
  • Magnetic Resonance Contrast Activity [MoA];
  • Osmotic Activity [MoA];
  • Osmotic Laxative [EPC];
  • Paramagnetic Contrast Agent [EPC];
  • Stimulation Large Intestine Fluid/Electrolyte Secretion [PE];
  • Vitamin B 12 [CS];
  • Vitamin B 6 [Chemical/Ingredient];
  • Vitamin B12 [EPC];
  • Vitamin B6 Analog [EPC];
  • Vitamin C [EPC]

Labeler Information

Labeler Name: Centurion Labs, LLC
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number:
Marketing Category: UNAPPROVED DRUG OTHER
Start Marketing Date:6/14/2009

Package Information

No. Package Code Package Description Billing Unit
123359-100-10100 CAPSULE in 1 BOTTLE (23359-100-10)EA
223359-100-3030 CAPSULE in 1 BOTTLE (23359-100-30)EA

NDC Record

Field Name Field Value Definition
PRODUCT NDC23359-100The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMEHUMAN PRESCRIPTION DRUGIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAMECentratexThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
NON PROPRIETARY NAMEIron, Sodium Ascorbate, Thiamine Mononitrate, Riboflavin, Pyridoxine Hydrochloride, Folic Acid, Cyanocobalamin, Niacinamide, Calcium Pantothenate, Zinc Sulfate, Magnesium Sulfate, Manganese Sulfate, and Cupric Sulfate AnhydrousThe non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMECAPSULEThe translation of the dosage form Code submitted by the firm.
ROUTE NAMEORALThe translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE6/14/2009This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAMEUNAPPROVED DRUG OTHERProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAMECenturion Labs, LLCName of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAMECALCIUM PANTOTHENATE; CUPRIC SULFATE ANHYDROUS; CYANOCOBALAMIN; FOLIC ACID; IRON; MAGNESIUM SULFATE, UNSPECIFIED; MANGANESE SULFATE; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; SODIUM ASCORBATE; THIAMINE MONONITRATE; ZINC SULFATEAn active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH10; .8; 15; 1; 106; 6.9; 1.3; 30; 5; 6; 200; 10; 18.2 
ACTIVE INGRED UNITmg/1; mg/1; ug/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1 
PHARM CLASSESAnalogs/Derivatives [Chemical/Ingredient], Ascorbic Acid [CS], Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Magnetic Resonance Contrast Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Paramagnetic Contrast Agent [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Vitamin B 12 [CS], Vitamin B 6 [Chemical/Ingredient], Vitamin B12 [EPC], Vitamin B6 Analog [EPC], Vitamin C [EPC] 

Download Record

Download this NDC record in Text format: Export

Download this NDC record in Excel (CSV) format: Export

Download this NDC record in XML format: Export

This page was last updated on: 2/1/2023